tradingkey.logo

Sight Sciences Inc

SGHT
View Detailed Chart

3.310USD

+0.040+1.22%
Market hours ETQuotes delayed by 15 min
170.06MMarket Cap
LossP/E TTM

Sight Sciences Inc

3.310

+0.040+1.22%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.22%

5 Days

-5.16%

1 Month

-21.38%

6 Months

+21.25%

Year to Date

-9.07%

1 Year

-47.54%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 7 analysts
HOLD
Current Rating
3.933
Target Price
20.29%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

117
Total
6
Median
8
Average
Company name
Ratings
Analysts
Sight Sciences Inc
SGHT
7
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
28
1
2
3
...
24

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(8)
Neutral(1)
Buy(1)
Indicators
Sell(3)
Neutral(1)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.041
Sell
RSI(14)
39.185
Neutral
STOCH(KDJ)(9,3,3)
18.340
Oversold
ATR(14)
0.195
Low Volatility
CCI(14)
-244.499
Oversold
Williams %R
76.812
Sell
TRIX(12,20)
-0.539
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
3.410
Sell
MA10
3.488
Sell
MA20
3.493
Sell
MA50
3.793
Sell
MA100
3.304
Buy
MA200
3.487
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma and the SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is a wearable eyelid technology that delivers targeted and adjustable heat to the meibomian glands of the eyelids in adult patients with evaporative dry eye disease due to meibomian gland disfunction.
Ticker SymbolSGHT
CompanySight Sciences Inc
CEOMr. Paul Badawi
Websitehttps://www.sightsciences.com/
KeyAI